Literature DB >> 20354507

Prevalence of incidental pancreatic cysts in the adult population on MR imaging.

Karen S Lee1, Aarti Sekhar, Neil M Rofsky, Ivan Pedrosa.   

Abstract

OBJECTIVES: The reporting of incidental pancreatic cystic lesions on cross-sectional imaging studies has dramatically increased over the last few years. The prevalence of incidental pancreatic cysts in the adult population, however, is unknown. The aim of our study was to determine the prevalence of incidentally detected pancreatic cysts in the adult population undergoing abdominal magnetic resonance (MR) imaging.
METHODS: MR imaging examinations of 616 consecutive patients obtained between January 2001 and February 2002 were retrospectively reviewed by two radiologists and the following information was recorded: the total number of pancreatic cysts; the maximum diameter, location, and characteristics of the largest cyst; documentation of the cyst(s) within the radiology report; and characteristics of the cyst(s) at imaging follow-up.
RESULTS: Incidental pancreatic cysts were present in 13.5% (83/616) of patients, with 60% of the cysts being solitary, and 88% of the cysts being simple. Largest cyst mean and median diameters were 7.4 mm (2-24 mm) and 6 mm, respectively. Both the prevalence of pancreatic cysts and the mean size of the largest cyst increased with age (P=0.007, r=0.893 and P=0.003, r=0.929, respectively). Only 31% (26/83) of incidental pancreatic cysts were documented in the radiology report. The mean size of reported pancreatic cysts was larger than those cysts that were not reported (P<0.001).
CONCLUSIONS: The prevalence of incidentally detected pancreatic cysts on MR imaging is 13.5%, and increases with age. A majority of these cysts are not reported on MR imaging studies.

Entities:  

Mesh:

Year:  2010        PMID: 20354507     DOI: 10.1038/ajg.2010.122

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  160 in total

1.  Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.

Authors:  Pari V Pandharipande; Curtis Heberle; Emily C Dowling; Chung Yin Kong; Angela Tramontano; Katherine E Perzan; William Brugge; Chin Hur
Journal:  Radiology       Date:  2014-11-12       Impact factor: 11.105

2.  Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Hanno Matthaei; Alexis L Norris; Athanasios C Tsiatis; Kelly Olino; Seung-Mo Hong; Marco dal Molin; Michael G Goggins; Marcia Canto; Karen M Horton; Keith D Jackson; Paola Capelli; Giuseppe Zamboni; Laura Bortesi; Toru Furukawa; Shinichi Egawa; Masaharu Ishida; Shigeru Ottomo; Michiaki Unno; Fuyuhiko Motoi; Christopher L Wolfgang; Barish H Edil; John L Cameron; James R Eshleman; Richard D Schulick; Anirban Maitra; Ralph H Hruban
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

3.  Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy.

Authors:  Roberto Valente; Gabriele Capurso; Paola Pierantognetti; Elsa Iannicelli; Matteo Piciucchi; Adriana Romiti; Paolo Mercantini; Alberto Larghi; Giulia Francesca Federici; Viola Barucca; Maria Falchetto Osti; Emilio Di Giulio; Vincenzo Ziparo; Gianfranco Delle Fave
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

4.  Incidentally discovered benign pancreatic cystic neoplasms not communicating with the ductal system: MR/MRCP imaging appearance and evolution.

Authors:  R Manfredi; M Bonatti; M D'Onofrio; S Mehrabi; R Salvia; W Mantovani; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

5.  851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital.

Authors:  Nakul P Valsangkar; Vicente Morales-Oyarvide; Sarah P Thayer; Cristina R Ferrone; Jennifer A Wargo; Andrew L Warshaw; Carlos Fernández-del Castillo
Journal:  Surgery       Date:  2012-07-06       Impact factor: 3.982

Review 6.  Clinical approach to incidental pancreatic cysts.

Authors:  Austin L Chiang; Linda S Lee
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

7.  Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms.

Authors:  Anne Marie Lennon; David Victor; Atif Zaheer; Mohammad Reza Ostovaneh; Jessica Jeh; Joanna K Law; Neda Rezaee; Marco Dal Molin; Young Joon Ahn; Wenchuan Wu; Mouen A Khashab; Mohit Girotra; Nita Ahuja; Martin A Makary; Matthew J Weiss; Kenzo Hirose; Michael Goggins; Ralph H Hruban; Andrew Cameron; Christopher L Wolfgang; Vikesh K Singh; Ahmet Gurakar
Journal:  Liver Transpl       Date:  2014-12       Impact factor: 5.799

8.  GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".

Authors:  Hanno Matthaei; Jian Wu; Marco Dal Molin; Chanjuan Shi; Sven Perner; Glen Kristiansen; Philipp Lingohr; Jörg C Kalff; Christopher L Wolfgang; Kenneth W Kinzler; Bert Vogelstein; Anirban Maitra; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

9.  Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults.

Authors:  Timothy B Gardner; Lisa M Glass; Kerrington D Smith; Gregory H Ripple; Richard J Barth; David A Klibansky; Thomas A Colacchio; Michael J Tsapakos; Arief A Suriawinata; Gregory J Tsongalis; J Marc Pipas; Stuart R Gordon
Journal:  Am J Gastroenterol       Date:  2013-10       Impact factor: 10.864

10.  TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions.

Authors:  Allison S Cohen; Jun Li; Matthew R Hight; Eliot McKinley; Allie Fu; Adria Payne; Yang Liu; Dawei Zhang; Qing Xie; Mingfeng Bai; Gregory D Ayers; Mohammed Noor Tantawy; Jarrod A Smith; Frank Revetta; M Kay Washington; Chanjuan Shi; Nipun Merchant; H Charles Manning
Journal:  Clin Cancer Res       Date:  2020-09-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.